Q32 Bio Inc. (QTTB) stock
QTTBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 8/30
$8.63+0.34 (+4.10%)
Close on Nov 17, 2026Market cap $256.91MP/E –Yield –
Q32 Bio operating margin
Operating margin is operating income as a percentage of revenue.
Q32 Bio's operating margin for the twelve months ending Jun 30, 2024 was -3570.1%. For fiscal 2025 it was 31.5%, against -4154.6% the year before. The highest annual figure on record is 31.5% in fiscal 2025.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 31.5% | +4186.1 |
| FY2022 | Dec 31, 2022 | -4154.6% | −3872.2 |
| FY2021 | Dec 31, 2021 | -282.4% | +4538.5 |
| FY2020 | Dec 31, 2020 | -4821.0% | +1778.2 |
| FY2019 | Dec 31, 2019 | -6599.2% | −5473.2 |
| FY2018 | Dec 31, 2018 | -1126.0% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2023 | Sep 30, 2023 | -419.5% | +3678.0 |
| Q2 FY2023 | Jun 30, 2023 | -227.0% | +3302.6 |
| Q1 FY2023 | Mar 31, 2023 | -250.2% | +4440.3 |
| Q4 FY2022 | Dec 31, 2022 | -4301.0% | −108.4 |
| Q3 FY2022 | Sep 30, 2022 | -4097.5% | −2269.2 |
| Q2 FY2022 | Jun 30, 2022 | -3529.6% | −2132.6 |
| Q1 FY2022 | Mar 31, 2022 | -4690.5% | −4686.7 |
| Q4 FY2021 | Dec 31, 2021 | -4192.6% | −1151.6 |
| Q3 FY2021 | Sep 30, 2021 | -1828.3% | +3158.1 |
| Q2 FY2021 | Jun 30, 2021 | -1397.0% | +4898.8 |
| Q1 FY2021 | Mar 31, 2021 | -3.8% | +6202.3 |
| Q4 FY2020 | Dec 31, 2020 | -3041.0% | +1498.8 |
| Q3 FY2020 | Sep 30, 2020 | -4986.4% | +2108.4 |
| Q2 FY2020 | Jun 30, 2020 | -6295.8% | +840.2 |
| Q1 FY2020 | Mar 31, 2020 | -6206.1% | +3098.7 |
| Q4 FY2019 | Dec 31, 2019 | -4539.8% | −2853.2 |
| Q3 FY2019 | Sep 30, 2019 | -7094.8% | −6118.8 |
| Q2 FY2019 | Jun 30, 2019 | -7136.0% | −6173.8 |
| Q1 FY2019 | Mar 31, 2019 | -9304.8% | −8357.4 |
| Q4 FY2018 | Dec 31, 2018 | -1686.6% | – |
| Q3 FY2018 | Sep 30, 2018 | -976.0% | – |
| Q2 FY2018 | Jun 30, 2018 | -962.2% | – |
| Q1 FY2018 | Mar 31, 2018 | -947.4% | – |
See a number that looks wrong?